Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Oculis Holding AG is a Switzerland-based company primally engaged in biotechnology sector. The Company is focused on the development of eye disease treatment for ophthalmology. It includes OCS-01, based on the OPTIREACH technology, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED) in a form of a single chain antibody fragment; and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and for other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The Company have operations in the USA, Europe and China. Ocullis deliver treatments to patients worldwide.
Find out what a historical investment in OCULIS HOLDING AG would be worth today using our OCS stock calculator.
Buying OCS shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in OCULIS HOLDING AG in minutes.
Sign up with some I.D. and zero paperwork
Add funds to your account
Make your first investment in OCS
What is the ticker symbol of OCULIS HOLDING AG?
The ticker symbol for OCULIS HOLDING AG is OCS.
How much is one share of OCS?
One share of OCS is valued at $7.44 as of 20 November 2026.
What is the market capitalisation of OCULIS HOLDING AG OCS?
As of 20 November 2026 OCULIS HOLDING AG has a market cap of $457.59M.
What is the 52-week high for OCULIS HOLDING AG stock?
The OCULIS HOLDING AG 52-week high stock price is $34.48.
What is the 52-week low for OCULIS HOLDING AG stock?
The OCULIS HOLDING AG 52-week low stock price is $6.78.
Can I buy OCS shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy OCS shares and over 13,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in OCS on Stake
Buy OCS from US$3 brokerage
Invest in 11,000+ U.S. stocks and ETFs
Own a slice of OCS from only US$10 with fractional shares